Effectiveness and safety of regimens containing linezolid for treatment of Mycobacterium abscessus pulmonary Disease

被引：0
作者：
Li-ping Cheng
Qing Zhang
Hai Lou
Xiao-na Shen
Qing-rong Qu
Jie Cao
Wei Wei
Wei Sha
Qin Sun
机构：
[1] Tongji University,Clinical and Research Center for Tuberculosis, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine
来源：
Annals of Clinical Microbiology and Antimicrobials | / 22卷
关键词：
Linezolid; Pulmonary Disease; Treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 45 条
  • [31] Treatment outcomes and relapse in patients with Mycobacterium avium-intracellulare complex pulmonary disease
    Chang, Chia-Ling
    Yu, Chong-Jen
    Hsueh, Po-Ren
    Chien, Jung-Yien
    MICROBIOLOGY SPECTRUM, 2023,
  • [32] Effectiveness and safety of acupuncture as an adjunctive therapy for chronic obstructive pulmonary disease: a randomised controlled trial
    Xu, Guixing
    Luo, Qin
    Sun, Mingsheng
    Huang, Liuyang
    Liu, Jiali
    Yang, Chunyan
    Huang, Qingsong
    Xiong, Chan
    Yang, Zuoqin
    Yang, Sha
    Zeng, Fang
    Liang, Fanrong
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2024, 24 (01)
  • [33] Tolerability, adverse events, and efficacy of treatment for Mycobacterium avium complex pulmonary disease in elderly patients
    Mori, Yuta
    Ito, Yutaka
    Takeda, Norihisa
    Fukumitsu, Kensuke
    Fukuda, Satoshi
    Kanemitsu, Yoshihiro
    Uemura, Takehiro
    Tajiri, Tomoko
    Ohkubo, Hirotsugu
    Maeno, Ken
    Oguri, Tetsuya
    Niimi, Akio
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (09) : 1255 - 1260
  • [34] Effectiveness, cost, and safety of four regimens recommended by WHO for RR/MDR-TB treatment: a cohort study in Eastern China
    Gu, Pengcheng
    Lu, Peng
    Ding, Hui
    Liu, Qiao
    Ding, Xiaoyan
    Chen, Yongfa
    Zhu, Limei
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [35] Efficacy and safety of intermittent maintenance therapy after successful treatment of Mycobacterium avium complex lung disease
    Asakura, Takanori
    Nakagawa, Taku
    Suzuki, Shoji
    Namkoong, Ho
    Morimoto, Kozo
    Ishii, Makoto
    Kurashima, Atsuyuki
    Betsuyaku, Tomoko
    Ogawa, Kenji
    Hasegawa, Naoki
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2019, 25 (03) : 218 - 221
  • [36] Efficacy and safety of cycloserine-containing regimens in the treatment of multidrug-resistant tuberculosis: a nationwide retrospective cohort study in China
    Wang, Jing
    Pang, Yu
    Jing, Wei
    Chen, Wei
    Guo, Ru
    Han, Xiqin
    Wu, Limin
    Yang, Guangxu
    Yang, Kunyun
    Chen, Cong
    Jiang, Lin
    Cai, Chunkui
    Dou, Zhi
    Diao, Lijuan
    Pan, Hongqiu
    Wang, Jianyun
    Du, Feifei
    Xu, Tao
    Wang, Lixia
    Li, Renzhong
    Chu, Naihui
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 763 - 770
  • [37] Effectiveness and safety of Suhuang Zhike capsule (sic) as adjuvant treatment for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and Meta-analysis
    Linfeng, Dai
    Yan, Zhuang
    Hai, Lue
    Mingqi, Chen
    Xing, Wang
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2023, 43 (02) : 231 - 238
  • [38] Isolation of Genetically Distinct Strains Within the Same Species During Treatment of Mycobacterium Avium Complex Pulmonary Disease
    Lee, Jiwon
    Park, Su-Jin
    Kim, Sangmi
    Lee, Han Na
    Sung, Heungsup
    Shim, Tae Sun
    Jo, Kyung-Wook
    CHEST, 2025, 167 (03) : 675 - 685
  • [39] Efficacy and Safety of Two-Drug Regimens That Are Approved from 2018 to 2022 for the Treatment of Human Immunodeficiency Virus (HIV) Disease and Its Opportunistic Infections
    Sivanandy, Palanisamy
    Yujie, Jess Ng
    Chandirasekaran, Kanini
    Seng, Ooi Hong
    Wasi, Nur Azrida Azhari
    MICROORGANISMS, 2023, 11 (06)
  • [40] Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients:: five year follow-up of patients receiving standardised treatment
    Jenkins, PA
    Campbell, IA
    RESPIRATORY MEDICINE, 2003, 97 (04) : 439 - 444
12345